Novo Nordisk | NVO - Należności Handlowe





Należności Handlowe Zmiana Data
ANI Pharmaceuticals USD 274.47M 19.04M 2026-06
Aurora Cannabis CAD 44.58M 3.68M 2026-03
Bausch Health Companies USD 2.26B 72M 2026-06
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Canopy Growth CAD 36.29M 104.13M 2026-03
Corcept Therapeutics USD 76.92M 37.85M 2026-06
Drreddys Laboratories INR 123.17B 121.76B 2026-03
Eli Lilly USD 23.48B 2.3B 2026-06
GlaxoSmithKline GBP 8.07B 137M 2026-06
Merck USD 12.21B 435M 2026-03
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Novartis USD 9.85B 252M 2026-06
Novo Nordisk DKK 114.94B 8.68B 2026-06
Novo Nordisk DKK 17.56B 82.7B 2026-06
Pacira USD 132.42M 6.78M 2026-06
Perrigo USD 697.1M 84.3M 2026-03
Phibro Animal Health USD 215.87M 2.02M 2025-12
Prestige Brands USD 187.36M 4.56M 2026-06
Sanofi EUR 492M 10M 2026-06
Supernus Pharmaceuticals USD 211.66M 29.47M 2026-06
Zoetis USD 1.57B 65M 2026-06